An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction
2022-06-23
عنوان الدراسة
An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction
داعم الدراسة
Roche
دواء الدراسة
Trastuzumab SC
رقم بروتوكول الدراسة
ML28851
حالة الدراسة
Terminated
موقع الدراسة
KKUH (Closed)
مرحلة الدراسة
3b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.